Novartis India Limited (NOVARTIND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 23.97B |
| Enterprise Value | 23.48B |
| P/E Ratio | 49.46 |
| PEG Ratio | -10.14 |
| Price/Sales Ratio | 13.05 |
| Price/Book Ratio | 5.91 |
| Enterprise/Revenue | 13.05 |
| Enterprise/EBITDA | 40.33 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.26 |
| Operating Margin | 0.27 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 3.54B |
| Revenue/Share | 150.09 |
| Gross Profit | 1.33B |
| EBITDA | 941M |
| Net Income | 931.8M |
| Diluted EPS | 37.74 |
Balance Sheet
| Total Cash | 6.68B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 331.23 |
Price History
| 52-Week Change | 95.98 |
| 52-Week High | 2,588.8 |
| 52-Week Low | 672.25 |
| Moving Average 50 Days | 1,744.64 |
| Moving Average 200 Days | 1,482.66 |
Statistics
| Average Volume | 102,519 |
| Shares Outstanding | 24.69M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
